[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349820-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349820-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","green-tea-catechins-and-prostate-cancer-mechanisms-clinical-evidence-and-safety-a-narrative-review","Green tea catechins and prostate cancer - mechanisms, clinical evidence, and safety: a narrative review","","Prostate cancer (PCa) remains a major cause of cancer mortality worldwide. This narrative review synthesizes literature on green tea catechins (GTCs) and their relationship to PCa, focusing on studies mainly published from 2016 to 2025. Evidence highlights epigallocatechin gallate (EGCG) as a predominant green tea flavanol with potential anticancer actions, including cell-cycle inhibition, oncogenic signalling modulation, and effects on androgen receptor activity and apoptosis. However, definitive clinical evidence for EGCG as a PCa therapeutic agent is still limited due to few trials, small samples, and variability in green tea formulations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/green-tea-catechins-and-prostate-cancer-mechanisms-clinical-evidence-and-safety-a-narrative-review/349820/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/green-tea-catechins-and-prostate-cancer-mechanisms-clinical-evidence-and-safety-a-narrative-review/349820.png","ImageObject",300,407,{"name":42,"@type":43},"Liam","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this narrative review on green tea catechins and prostate cancer?","Question",{"text":63,"@type":64},"It reviews existing literature to clarify the relationship between green tea catechins (GTCs) and prostate cancer and to summarize mechanisms, clinical evidence, and safety-related considerations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which green tea compound is highlighted as having the strongest therapeutic potential?",{"text":68,"@type":64},"Epigallocatechin gallate (EGCG), described as the predominant flavanol in green tea, is emphasized for its potential actions against prostate cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is conclusive clinical evidence for EGCG in prostate cancer still lacking?",{"text":72,"@type":64},"Clinical evidence remains limited because few human trials with small sample sizes are available and because green tea formulations vary across studies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349820,1790186464,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Altinoz and Sanlier BMC Cancer (2026) 26:191 [https://doi.org/10.1186/s12885-025-15516-8](https://doi.org/10.1186/s12885-025-15516-8)  \nBMC Cancer  \nRESEARCH Open Access  \nGreen tea catechins and prostate cancer: mechanisms, clinical evidence, and safety: a narrative review  \nHatice Berin Altinoz1 and Nevin Sanlier1*  \nAbstract  \nProstate cancer (PCa) is the second most common malignancy among men and the fifth leading cause of cancer-related mortality worldwide. In this study, a review of the literature was conducted in an attempt to clarify the relationship between green tea catechins (GTCs) and PCa. Published articles were searched using PubMed, Web of Science, Google Scholar, and Scopus databases. The study analysed the studies, which were mainly conducted between 2016 and 2025. Polyphenolic compounds are attracting increasing attention for their potential roles in cancer prevention and treatment, and many in vitro, animal, and clinical studies have explored the roles of polyphenols in cancer. Epigallocatechin gallate (EGCG), the predominant flavanol in green tea (GT), exerts significant therapeutic potential by inhibiting cell cycle progression, modulating oncogenic signalling, and interacting with nuclear transcription factors. These mechanisms suggest that EGCG may aid in PCa prevention and management, with evidence indicating that EGCG suppresses PCa cell proliferation by regulating androgen receptor activity and inducing apoptosis, potentially inhibiting tumour growth and metastasis. However, conclusive evidence supporting the use of EGCG as a therapeutic agent for PCa is still lacking. As detailed in this review, preclinical studies have demonstrated this compound’s promising anticancer activity, but clinical evidence on the effects of GTCs remains limited due to the small number of human trials and low sample sizes of studies conducted to date, as well as variability in GT formulations.  \nKeywords Green tea, Green tea catechins, Polyphenol, Epigallocatechin gallate, Prostate cancer  \nIntroduction  \nThe International Agency for Research on Cancer (IARC) estimated that approximately 20 million new cancer cases and 9.7 million cancer-related deaths occurred worldwide in 2022, with one in six of all deaths being due to cancer [1]. Prostate cancer (PCa) is the second most common cancer among men worldwide [2]. As cancer  \n*Correspondence:  \nNevin Sanlier  \n[nevintekgul@gmail.com](nevintekgul@gmail.com); [nevin.sanlier@ankaramedipol.edu.tr](nevin.sanlier@ankaramedipol.edu.tr)[ ](nevin.sanlier@ankaramedipol.edu.tr)1School of Health Sciences, Department of Nutrition and Dietetics Altındağ, Ankara Medipol University, Ankara, Turkey  \ncells grow and proliferate, the functions of the prostate gland are disrupted and health problems begin to occur [3]. Although the aetiology of PCa is not clearly understood, it is a multifactorial disease, and as the risk of developing PCa increases with age, the prognosis is generally worse and the mortality rate and speed of progression also increase [2, 4]. African American men have a higher incidence of PCa and a higher mortality rate than white American men, while the lowest PCa incidence is typically found in Asian men. In addition to genetic predispositions, the disease is also associated with dietary, lifestyle, social, and environmental factors [5, 6]. Five single-nucleotide polymorphisms have been identified  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party mater","cbCaioyuE8KVwVGX","https://ap.wps.com/l/cbCaioyuE8KVwVGX","pdf",1697692,14,"English","# Abstract\n# Introduction\n# Background and risk factors\n# Biological mechanisms of green tea catechins\n# Clinical evidence and safety considerations","[{\"question\":\"What is the purpose of this narrative review on green tea catechins and prostate cancer?\",\"answer\":\"It reviews existing literature to clarify the relationship between green tea catechins (GTCs) and prostate cancer and to summarize mechanisms, clinical evidence, and safety-related considerations.\"},{\"question\":\"Which green tea compound is highlighted as having the strongest therapeutic potential?\",\"answer\":\"Epigallocatechin gallate (EGCG), described as the predominant flavanol in green tea, is emphasized for its potential actions against prostate cancer.\"},{\"question\":\"Why is conclusive clinical evidence for EGCG in prostate cancer still lacking?\",\"answer\":\"Clinical evidence remains limited because few human trials with small sample sizes are available and because green tea formulations vary across studies.\"}]","Green tea catechins and prostate cancer - mechanisms, clinical evidence, and safety: a narrative review | PDF",1790085772,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8524f1510684f015df2df67698287cc7.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e44cf0d3c178fd9907d5e33a483d1d08.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e659efea75e474763c8d83fcc54c8aea.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/949545a00daa991e2c0e7f2f0afe3e8e.webp",980,1306]